+91 9650760803 
Published: October 14, 2021 | Updated: July 17, 2026
Key Takeaways
- 01. Therapy overview:
The treatment uses umbilical cord–derived mesenchymal stem cells (WJ-MSCs) to aid pancreas repair, enhance insulin production, and help lower glucose levels. - 02. Implementation details:
The procedure includes donor stem cell extraction, HLA matching, and cGMP-compliant lab processing. Cells are infused through methods such as intravenous, intramuscular, intrathecal, intra-arterial, or subcutaneous routes. - 03. Reported outcomes:
Among 122 diabetes patients (53 type 1, 78 type 2), around 32% of type 1 and 50% of type 2 patients experienced improved glucose stability. About 38 patients reported reduced medication use — roughly 60% in type 2 and 29% in type 1 cases. - 04. Important caution:
The therapy remains experimental with individual-specific outcomes. It is not a guaranteed cure, and no fetal or embryonic stem cells are used.
Diabetes mellitus is a chronic metabolic disorder in which the body is unable to regulate blood glucose (sugar) levels effectively. Normally, the pancreas releases insulin, a hormone that allows glucose from digested food to move out of the bloodstream and into cells, where it is used for energy. When insulin production is insufficient, or when the body’s cells stop responding properly to insulin, glucose accumulates in the blood instead of being used — a state that, left unmanaged, damages blood vessels, nerves, and organs over time.
There are three principal forms of the condition:
- Type 1 Diabetes — an autoimmune condition in which the immune system destroys the insulin-producing beta cells of the pancreas.
- Type 2 Diabetes — a progressive condition driven by insulin resistance, often linked with genetics, weight, and lifestyle.
- Gestational Diabetes — a temporary form of insulin resistance that develops during pregnancy due to hormonal changes.
Diabetes is one of the fastest-growing chronic conditions worldwide, closely tied to rising rates of obesity and sedentary lifestyles. If poorly controlled over years, it can lead to serious complications, including cardiovascular disease, vision loss, diabetic nephropathy (kidney damage), diabetic neuropathy (nerve damage), and non-healing diabetic foot ulcers.
Because diabetes management traditionally revolves around lifelong medication, insulin injections, and strict lifestyle discipline, many patients look for options that go beyond symptom control and address the underlying pancreatic and immune dysfunction. This has driven growing interest in regenerative approaches such as mesenchymal stem cell (MSC) therapy, which is being studied for its potential to support beta cell function, reduce inflammation, and improve metabolic regulation. Viezec offer investigational stem cell programs for diabetes in Delhi, India alongside comprehensive patient support and travel assistance for domestic and international patients.
Understanding why diabetes develops helps explain why researchers are exploring stem cell–based approaches rather than medication alone.
Type 1 Diabetes
Type 1 diabetes is an autoimmune disorder. For reasons not fully understood, the immune system mistakenly identifies the insulin-producing beta cells inside the pancreas as foreign and destroys them. Once enough beta cells are lost, the body can no longer produce adequate insulin. Genetic predisposition appears to play a role, and some researchers believe viral infections may act as a trigger that sets off the immune attack in genetically susceptible individuals. This condition typically develops in childhood or early adulthood, though it can occur at any age.
Type 2 Diabetes
Type 2 diabetes results from a combination of genetic susceptibility and lifestyle factors. Excess body weight — particularly abdominal fat — makes cells more resistant to insulin’s effects, forcing the pancreas to work harder to keep glucose levels normal. Over years, the pancreas may struggle to keep up with this demand. Family history significantly increases risk, since relatives often share both genetic tendencies and lifestyle patterns that contribute to the disease. Physical inactivity, poor diet, and age are additional contributing factors.
Gestational Diabetes
During pregnancy, the placenta produces hormones that can make the mother’s cells less responsive to insulin, a normal adaptation that sometimes goes too far and leads to elevated blood sugar. Women who are overweight prior to pregnancy, or who gain significant weight during it, face a higher risk of developing this temporary but medically significant form of diabetes.
Understanding the root cause matters because the two major types differ mechanistically — Type 1 is primarily an immune problem, while Type 2 is primarily a metabolic/resistance problem. This distinction shapes how stem cell treatment protocols are tailored for each type. Read more about the specific mechanisms in Type 1 Diabetes and Type 2 Diabetes.
Symptoms
Recognizing the early warning signs of diabetes is essential for timely diagnosis and intervention. Common symptoms include:
- Persistent fatigue and low energy
- Unexplained weight loss
- Intense or unusual hunger, even after eating
- Increased thirst that doesn’t go away
- Frequent urination, including at night
- Difficulty concentrating or reduced mental sharpness
- Numbness, tingling, or a “pins and needles” sensation in the hands or feet — an early sign of diabetic neuropathy
- Blurred vision
- Recurrent skin or gum infections
- Slow-healing cuts, sores, or wounds, particularly on the feet — a warning sign that can progress to diabetic foot ulcers if untreated
These symptoms often develop gradually, especially in Type 2 diabetes, which is why the condition frequently goes undiagnosed for years. If you notice a combination of these symptoms, it’s important to consult a physician and undergo proper diagnostic testing rather than waiting for symptoms to worsen. Early detection allows for earlier intervention — whether through conventional management or evaluation for options such as regenerative therapy.
Diagnosing diabetes, or identifying pre-diabetes, relies on a set of standardized blood tests. These same tests are also used to assess a patient’s baseline metabolic status before considering stem cell treatment.
The A1C Test
Measures average blood sugar levels over the past two to three months by looking at the percentage of hemoglobin coated with sugar.
| Category | Result |
|---|---|
| Normal | Below 5.7% |
| Pre-diabetic | 5.7% – 6.4% |
| Diabetic | 6.5% or above |
The FPG (Fasting Plasma Glucose) Test
Measures blood sugar after at least eight hours of fasting.
| Category | Result |
|---|---|
| Normal | Below 110 mg/dl |
| Impaired Fasting Glucose (pre-diabetes) | 110 – 125 mg/dl |
| Diabetic | 126 mg/dl or above |
The OGTT (Oral Glucose Tolerance Test)
Measures blood sugar two hours after drinking a glucose-rich beverage.
| Category | Result |
|---|---|
| Normal | Below 140 mg/dl |
| Impaired Glucose Tolerance (pre-diabetes) | 140 – 199.9 mg/dl |
| Diabetic | 200 mg/dl or above |
Beyond these three tests, our medical team also reviews a patient’s complete history — including complications such as nerve damage, kidney function, and wound healing — to build a full clinical picture. This evaluation determines eligibility and helps decide whether a patient may be a suitable candidate for the stem cell treatment protocol described below.
How Stem Cell Therapy for Diabetes Works, Step by Step
Research into Mesenchymal Stem Cells (MSCs) — particularly those derived from Wharton’s Jelly (WJ-MSCs) in the umbilical cord — has explored their ability to support tissue repair, encourage the formation of new blood vessels (neovascularization), and modulate an overactive immune response. Unlike medications, which primarily manage symptoms, this investigational approach is being studied for its potential to influence the underlying biological processes involved in diabetes.
WJ-MSCs are considered a favorable source for research because collection is non-invasive and pain-free for the donor, the cells can be cryogenically banked, and they are well suited to laboratory expansion under controlled conditions. The overall treatment pathway generally includes the following stages:
- Qualification for Treatment — A thorough review of the patient’s medical history, current symptoms, and disease progression, supported by laboratory tests (see Diagnosis), to determine whether the patient may be an eligible candidate.
- Source Extraction — With physician guidance, the stem cell source is finalized. For allogeneic (donor-based) therapy, Human Leukocyte Antigen (HLA) matching is performed between the patient and donor to reduce the risk of rejection and improve compatibility.
- Laboratory Processing — Extracted samples are sent to a government-approved, cGMP-compliant laboratory. Processing follows ISO and GMP quality standards, and each batch is accompanied by a third-party certificate of analysis confirming purity and safety (see Quality Certificate).
- Stem Cell Implantation — Once processed, cells are administered via the delivery method best suited to the patient’s condition (see Implantation).
- Aftercare and Monitoring — Patients undergo structured follow-up evaluations to track response over time.
This is an evolving field of regenerative medicine, and outcomes are individual-specific. To understand how sample processing and quality assurance work in more depth, visit our dedicated page on Stem Cell Processing.
Implantation
The route by which stem cells are delivered into the body is chosen based on each patient’s clinical condition, the target tissue, and overall health status. Commonly used delivery methods include:
- Intravenous (IV) administration — cells are infused directly into the bloodstream, allowing systemic circulation.
- Intrathecal administration (lumbar puncture) — used when nervous system involvement, such as neuropathy, needs to be addressed.
- Intramuscular injection — delivers cells directly into muscle tissue.
- Intra-arterial delivery — targets a specific organ or region by infusing through an artery supplying that area.
- Subcutaneous injection — delivered just beneath the skin.
- Liberation angioplasty — used in cases involving vascular compromise.
- Surgical administration — reserved for specific complex cases, such as those seen in stroke recovery protocols.
The chosen combination of methods aims to maximize the cells’ potential reach to the pancreas and affected tissues while minimizing risk. For a deeper technical explanation of each delivery route, see our page on Stem Cell Delivery Methods.
Mechanism
Mesenchymal Stem Cells are the primary cell type studied for diabetes-related regenerative therapy. Research suggests several possible mechanisms of action:
- Pancreatic support — MSCs are being studied for their potential to aid repair processes within pancreatic tissue, which may help improve the organ’s capacity to process glucose.
- Neovascularization — the formation of new blood vessels can improve blood supply to damaged tissue, which is particularly relevant for complications like diabetic foot ulcers and diabetic neuropathy.
- Immunomodulation — in autoimmune-driven Type 1 diabetes, MSCs are studied for their ability to help regulate an overactive immune response that targets beta cells.
- Anti-inflammatory signaling — MSCs release signaling molecules that may help reduce chronic low-grade inflammation associated with insulin resistance in Type 2 diabetes.
These combined actions are the basis of ongoing clinical research (see Scientific References) into whether MSC-based therapy can meaningfully influence disease progression rather than only manage symptoms. To learn more about the broader biological principles behind this approach, visit our page on the Physiological Mechanism of Stem Cells.
Our Promise
Because regenerative medicine is still an evolving field, patients deserve transparency, safety, and consistent support throughout their journey. Our commitment includes:
- Prioritizing patient well-being in every recommendation and treatment decision.
- Remaining available to patients throughout their treatment journey for questions, concerns, or updates.
- Providing dedicated case coordination so patients can focus on recovery rather than logistics.
- Upholding international safety and quality standards at every step of sourcing, processing, and delivery.
- Maintaining strict quality control over stem cell purity, in compliance with recognized laboratory standards.
To understand why many international patients choose India for regenerative treatment — including cost, infrastructure, and expertise — visit Why Stem Cell Therapy in India.
Frequently Asked Questions
What is stem cell treatment for diabetes?
Stem cell treatment for diabetes involves using specialized stem cells to regenerate insulin-producing beta cells in the pancreas, potentially improving blood sugar control.
Who can benefit from stem cell therapy for diabetes?
Patients with type 1 diabetes, type 2 diabetes with poor glycemic control, or those facing complications may be candidates, depending on individual evaluation by specialists.
How is the therapy administered?
Stem cells are typically delivered intravenously or through targeted injections to the pancreas under strict clinical supervision, ensuring precise delivery and safety.
Is stem cell therapy safe for diabetes patients?
When conducted in certified clinics by experienced medical teams, stem cell therapy is generally safe. Mild side effects may include temporary fever, fatigue, or minor injection site reactions.
How long does it take to see improvements?
Results may be observed gradually over weeks to months. Blood sugar levels, insulin requirements, and overall metabolic function may improve depending on individual response.
How many sessions are required?
The number of sessions depends on the patient’s condition and response. Typically, 1–3 sessions are recommended, followed by regular monitoring and follow-ups.
Can stem cell therapy replace insulin or medications?
Stem cell therapy is often used as a complementary treatment and may reduce insulin or medication dependence, but it is not a guaranteed replacement. Ongoing medical management is essential.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the appointment form on our website. Our specialists will assess eligibility and provide a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
Improvements
Reported outcomes associated with stem cell–based approaches to diabetes span several dimensions of health, including:
- Metabolic control and glucose stability
- Beta cell function
- Immunological regulation (particularly relevant in Type 1 diabetes)
- Reduction in systemic inflammation
- Overall quality-of-life indicators, including energy levels and wound healing
It’s important to note that these improvements are not uniform — they vary from patient to patient based on diabetes type, disease duration, and individual biology, and cannot be guaranteed. Related complications, such as diabetic nephropathy and diabetic foot ulcers, are evaluated separately as part of a comprehensive treatment plan.
Quality Certificate
Patient safety depends heavily on rigorous laboratory and quality-control standards. Before any stem cell sample is considered for treatment:
- All cells undergo infection screening to rule out contamination.
- The culture medium used for harvesting, preservation, and delivery is closely examined.
- The final wash of the stem cell source is tested for both aerobic and anaerobic microbial contamination.
- An endotoxin test is performed, and only batches below the accepted threshold are approved for use.
- Every finalized batch is issued a Certificate of Analysis, confirming it meets required purity and safety benchmarks.
This process is designed to ensure that every sample used meets internationally recognized laboratory standards. Learn more about why these standards matter in Why Stem Cell Therapy in India.
Follow-Up
Post-treatment monitoring is a core part of the overall care plan. Our team typically follows up with patients at approximately one month, two months, and six months after treatment to track progress, document any changes in symptoms, and refine care recommendations where needed. Patients can also request additional support or consultation at any point beyond these scheduled check-ins through our contact page.
Treatment Results
In a review of 122 diabetes patients (53 Type 1, 78 Type 2) who underwent stem cell–based treatment and were evaluated post-procedure:
- Among Type 1 patients, roughly 32% reported improved stability in blood glucose levels, and around 35% reported fewer episodes of hypoglycemia.
- Among Type 2 patients, about 50% reported improved blood glucose stability, over 39% reported fewer neuropathic symptoms, 41.5% reported reduced numbness, and nearly 45% reported improved sensation in the legs.
- 79 patients showed reduced HbA1c values in post-treatment lab results.
- Improvements in HbA1c for Type 1 patients tended to appear within the first 3–6 months, while for Type 2 patients, benefits were more often observed after six months or longer, suggesting differing timelines of response between the two types.
- 38 patients reported reduced medication requirements — approximately 60% among Type 2 patients and 29% among Type 1 patients.
These figures reflect real-world case review data and are shared for informational purposes; they are not a guarantee of outcome for any individual patient. For visual patient accounts, see our Patient Videos or explore our full YouTube channel.
Testimonials
Rakesh K. – Delhi, India – February 2020 – ⭐⭐⭐⭐☆
“I was dependent on daily insulin for years. After Viezec’s stem cell therapy, my sugar levels stabilized, and my insulin need reduced.”
Emma J. – London, UK – July 2020 – ⭐⭐⭐⭐⭐
“Type 1 diabetes controlled my life. Post-treatment at Viezec, my energy improved, and I can manage with fewer injections.”
Ahmed N. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“My HbA1c levels were always high. After stem cell therapy at Viezec, my sugar levels came under control, and I feel healthier.”
Isabella T. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“I struggled with diabetes complications for years. Viezec’s therapy reduced my fatigue, and I now enjoy an active lifestyle.”
Omar Y. – Amman, Jordan – September 2021 – ⭐⭐⭐⭐☆
“Type 2 diabetes left me exhausted. After Viezec’s treatment, my blood sugar stabilized, and my medication dosage decreased.”
Hannah R. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“Living with diabetes was overwhelming. After therapy at Viezec, my glucose readings improved, and I feel more energetic.”
George D. – Sydney, Australia – August 2022 – ⭐⭐⭐⭐☆
“My diabetes caused nerve pain. Post stem cell therapy at Viezec, my blood sugar stabilized, and the pain has reduced greatly.”
Fatima H. – Istanbul, Turkey – April 2023 – ⭐⭐⭐⭐⭐
“I was at risk of kidney damage from diabetes. Viezec’s therapy improved my overall health, and my sugar control is much better now.”
Lucas P. – São Paulo, Brazil – October 2023 – ⭐⭐⭐⭐☆
“I had uncontrolled diabetes despite medication. After treatment at Viezec, my insulin use reduced, and I feel active again.”
Maria S. – Madrid, Spain – May 2025 – ⭐⭐⭐⭐⭐
“Diabetes was affecting my vision and energy. Thanks to Viezec’s stem cell therapy, my sugar levels are stable, and I feel renewed.”
Diabetes Latest Blogs
Stem Cell Therapy Offers Alternative Treatment for Type 1 & Type 2 Diabetes
Type 1 diabetes mellitus is a chronic condition defined by the body’s inability to generate insulin. Adult stem cells may have the potential to ameliorate and perhaps cure the consequences of the disease. According to the American Diabetes Association, about 1.25 million Americans have type 1 diabetes, with an estimated 40,000 new cases diagnosed each year.
Stem Cell Therapy For Type 2 Diabetes In India
Diabetes is counted as one serious ailment that cannot be cured by itself. Diabetes treatment has come to the respite of patients via well-known institutes. Diabetes is triggered because of high blood sugar levels in the blood (high blood glucose) affecting the metabolism
Can Diabetes Be Cured By Stem Cell Therapy?
Virtually 400 million individuals universally are living with diabetes, and that number is anticipated to jump to virtually 600 million by 2035, as per the International Diabetes Federation. For several individuals, diabetes can be controlled with diet, workouts,s and, often, insulin or other medications. However, impediments from diabetes can be serious and consist of kidney failure, nerve impairment, vision loss, heart ailments, and a swarm of other health concerns.
Stem Cell Therapy for Diabetes
The most imperative portion of a Type 1 diabetes treatment plan is handling blood glucose levels. When if you identify with this disease, you should work meticulously with your doctor so as to find a plan of treatment that is correct for you – treatments might differ as per spiritual beliefs or other health complications involved. There are diverse kinds of medical treatment and also natural treatments and management tactics.
Click Here For More Blogs
Diabetes Happy Patient Video’s
Patient with Stroke, Diabetes, Hypertension and ED Disease shares his experience..Watch Video
Mohammad Anas from Dubai/Gurgaon came for Diabetes Mellitus and Neuropathy Treatment..Watch Video
Laxmi Devi from Jharkhand Came Us for Stem Cell Treatment of Diabetes & CKD..Watch Video
Patient with Diabetes Mellitus, Neuropathy and Retinopathy shares her experience..Watch Video
Before undergoing this procedure, patients should understand that stem cell therapy remains an experimental, investigational approach and may not produce the desired effect in every case. Depending on a patient’s evaluation, treatment may be declined, or the recommended protocol may be adjusted based on individual health status.
Our priority is providing the safest, most current techniques available, in line with recognized international standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ from patient to patient even with similar diagnoses. No fetal or embryonic stem cells are used in any of our treatment protocols.
Related Conditions We Treat
Diabetes-related: Type 1 Diabetes · Type 2 Diabetes · Diabetic Foot Ulcers · Diabetic Neuropathy · Diabetic Nephropathy
Other categories: Neuro Disorders · Organ Specific Treatments · Eye Disorders · Orthopedic Treatments · Aging & Longevity
Get started: Book an Appointment · Talk to Our Experts · Stem Cell FAQ
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for diabetes.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
Other Disease Treatment
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
